Abeona Therapeutics announces new gene therapy facility, stock offering
Story excerpt provided by The Plain Dealer.
Written by Julie Washington.
Like a World Series team on a streak, Cleveland-based Abeona Therapeutics Inc. got hot in October.
Abeona Therapeutics is a clinical-stage biopharmaceutical company developing gene and cell therapies for life-threatening rare genetic diseases. Its strategy is to re-engineer viruses – which usually spread disease – to instead save lives.
Click here to read the complete article.
Originally published November 1, 2017.
Leave a Reply